CENX vs SRPT · P/E 15, rev $1.40B vs rev $1.13B
Century Aluminum Company (CENX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Century Aluminum Company (CENX) is a aluminum company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CENX revenue for 2026-06-30 was $1.40B. Net income was $586.8M. CENX currently screens at market cap $1.76B and trailing P/E 15.5.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
CENX currently screens at market cap $1.76B and trailing P/E 15.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CENX and SRPT stock pages for the full models.
Not investment advice.